TY - JOUR
T1 - Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)
AU - Lippi, Giuseppe
AU - Baird, Geoffrey S.
AU - Banfi, Giuseppe
AU - Bölenius, Karin
AU - Cadamuro, Janne
AU - Church, Stephen
AU - Cornes, Michael P
AU - Dacey, Anna
AU - Guillon, Antoine
AU - Hoffmann, Georg
AU - Nybo, Mads
AU - Premawardhana, Lakdasa Devananda
AU - Salinas, María
AU - Sandberg, Sverre
AU - Slingerland, Robbert
AU - Stankovic, Ana
AU - Sverresdotter, Sylte Marit
AU - Vermeersch, Pieter
AU - Simundic, Ana-Maria
AU - European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)
PY - 2017
Y1 - 2017
N2 - It is now undeniable that laboratory testing is vital for the diagnosis, prognostication and therapeutic monitoring of human disease. Despite the many advances made for achieving a high degree of quality and safety in the analytical part of diagnostic testing, many hurdles in the total testing process remain, especially in the preanalytical phase ranging from test ordering to obtaining and managing the biological specimens. The Working Group for the Preanalytical Phase (WG-PRE) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has planned many activities aimed at mitigating the vulnerability of the preanalytical phase, including the organization of three European meetings in the past 7 years. Hence, this collective article follows the previous three opinion papers that were published by the EFLM WGPRE on the same topic, and brings together the summaries of the presentations that will be given at the 4th EFLM-BD meeting "Improving quality in the preanalytical phase through innovation" in Amsterdam, 24-25 March, 2017.
AB - It is now undeniable that laboratory testing is vital for the diagnosis, prognostication and therapeutic monitoring of human disease. Despite the many advances made for achieving a high degree of quality and safety in the analytical part of diagnostic testing, many hurdles in the total testing process remain, especially in the preanalytical phase ranging from test ordering to obtaining and managing the biological specimens. The Working Group for the Preanalytical Phase (WG-PRE) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has planned many activities aimed at mitigating the vulnerability of the preanalytical phase, including the organization of three European meetings in the past 7 years. Hence, this collective article follows the previous three opinion papers that were published by the EFLM WGPRE on the same topic, and brings together the summaries of the presentations that will be given at the 4th EFLM-BD meeting "Improving quality in the preanalytical phase through innovation" in Amsterdam, 24-25 March, 2017.
KW - errors
KW - innovation
KW - laboratory medicine
KW - preanalytical variability
KW - quality
U2 - 10.1515/cclm-2017-0107
DO - 10.1515/cclm-2017-0107
M3 - Journal article
C2 - 28231060
AN - SCOPUS:85016076504
SN - 1434-6621
VL - 55
SP - 489
EP - 500
JO - Clinical Chemistry and Laboratory Medicine
JF - Clinical Chemistry and Laboratory Medicine
IS - 4
ER -